Cargando…
Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides
Targeting PD-1 is an important component of many immune checkpoint blockade (ICB) therapeutic approaches. However, ICB is not an efficacious strategy in a variety of cancer types, in part due to immunosuppressive metabolites in the tumor microenvironment (TME). Here, we find that αPD-1-resistant can...
Autores principales: | Schofield, James H., Longo, Joseph, Sheldon, Ryan D., Albano, Emma, Hawk, Mark A., Murphy, Sean, Duong, Loan, Rahmy, Sharif, Lu, Xin, Jones, Russell G., Schafer, Zachary T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515953/ https://www.ncbi.nlm.nih.gov/pubmed/37745450 http://dx.doi.org/10.1101/2023.09.14.557799 |
Ejemplares similares
-
Amino acid positions near the active site determine the reduced activity of human ACOD1 compared to murine ACOD1
por: Chen, Fangfang, et al.
Publicado: (2023) -
Mitochondrial ACOD1/IRG1 in infection and sterile inflammation()
por: Wu, Runliu, et al.
Publicado: (2022) -
Macrophages inhibit Coxiella burnetii by the ACOD1‐itaconate pathway for containment of Q fever
por: Kohl, Lisa, et al.
Publicado: (2022) -
Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020) -
Sirt3 improves monosodium urate crystal-induced inflammation by suppressing Acod1 expression
por: Lv, Linxi, et al.
Publicado: (2023)